Regeneron Pharmaceuticals and Tessera Therapeutics sign a $275 million deal to develop TSRA-196, a potential one-time #GeneEditing therapy for Alpha-1 Antitrypsin Deficiency.
#News #deal #partneship #GeneTherapy #AATD #Pharma
Hashtag
#Partneship
Advertisement · 728 × 90
0
0
0
0
Regeneron Pharmaceuticals and Tessera Therapeutics sign a $275 million deal to develop TSRA-196, a potential one-time #GeneEditing therapy for Alpha-1 Antitrypsin Deficiency.
#News #deal #partneship #GeneTherapy #AATD #Pharma
0
0
0
0
Yankton Medical Clinic, P.C. is pleased to announce a new educational partnership with Southeast Technical College's Nursing program. Beginning this fall, the clinic will proudly serve as a clinical rotation site for Southeast Tech nursing students.
buff.ly/Ews3FAk
#MED #YMC #Partneship
0
0
0
0